To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

Name: To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
Published: 2014
License: Public Domain

Mundipharma Research GmbH & Co KG · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

malignant pain, non-malignant pain, oxycodone naloxone combination, severe chronic and non-malignant pain, malignant and non-malignant pain that requires around-the clock opioid therapy, interventional, phase2, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

Related documents